下垂体腺酸环酶激活聚胺信号作为偏头痛治疗点
Håkan Ashina1,2, Rune H Christensen1,2,3, Debbie L Hay4
1Department of Neurology, Danish Headache Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Nature reviews. Neurology
|September 10, 2024
概括
pituitary adenylate cyclase-activating polypeptide (PACAP) 在偏头痛的发病过程中起着关键的作用. 针对PACAP信号显示出开发新型偏头痛预防疗法的前景.
科学领域:
- 神经学 神经学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛是一种致残的神经系统疾病,影响全球超过10亿人.
- 它的确切病原体尚未完全理解,但涉及到特定的信号分子.
- pituitary adenylate cyclase-activating polypeptide (PACAP) 是一种关键的血管活性,与偏头痛发作有关.
研究的目的:
- 探索PACAP信号传递在trigeminovascular系统中的分子和细胞机制.
- 为了阐明PACAP在偏头痛病原体中的作用.
- 讨论针对PACAP治疗偏头痛的新兴治疗策略.
主要方法:
- 关于PACAP和偏头痛的当前科学文献的综述.
- 对PACAP信号传递的分子和细胞机制的分析.
- 对PACAP向治疗的临床试验数据的讨论.
主要成果:
- PACAP被认为是偏头痛启动和调节中的重要信号分子.
- 有证据表明,PACAP有助于三角神经血管系统在偏头痛中的作用.
- 一项II期试验表明,针对PACAP的单克隆抗体对偏头痛预防有效.
结论:
- 在偏头痛的发病过程中,PACAP信号非常重要.
- 准PACAP为偏头痛预防提供了一个有前途的治疗途径.
- 需要进一步的研究来将PACAP向策略转化为临床治疗.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
Amplifying Signals via Second Messengers
6.8K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
6.8K


